Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10361659 | 0.75 | KDM4E (0.32) | KDM4EMAPT | |
| SCHEMBL2979879 | 0.71 | KDM4E (0.34) | KDM4EMAPT | |
| SCHEMBL31307328 | 0.69 | — | — | |
| SCHEMBL3388937 | 0.69 | KDM4E (0.31) | KDM4EMAPT | |
| SCHEMBL27963354 | 0.67 | GAA (0.35) | KDM4EMAPT | |
| SCHEMBL19462668 | 0.65 | — | — | |
| SCHEMBL11121679 | 0.64 | KDM4E (0.36) | KDM4EMAPT | |
| SCHEMBL9308229 | 0.64 | KDM4E (0.36) | KDM4EMAPT | |
| SCHEMBL10457383 | 0.63 | ALDH1A1 (0.41) | — | |
| SCHEMBL5069504 | 0.63 | ALDH1A1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070029279-A1 | Wood treating formulation | WOOD POLYMER TECHNOLOGIES ASA (NO) | 2007-02-08 | — | — | US | claimed |
| EP-1253998-B1 | WOOD IMPREGNATION | WOOD POLYMER TECHNOLOGIES ASA (NO) | 2004-03-24 | — | — | EP | claimed |
| US-20010033922-A1 | Wood impregnation | KEBONY ASA (NO) | 2001-10-25 | — | — | US | claimed |
| US-9624225-B2 | Quinolinyl modulators of RORγt | JANSSEN PHARMACEUTICA NV (BE) | 2017-04-18 | — | — | US | disclosed |
| US-20150111870-A1 | QUINOLINYL MODULATORS OF RORyt | JOHNSON & JOHNSON (US) | 2015-04-23 | — | — | US | disclosed |
| EP-1658162-B1 | WOOD TREATING FORMULATION | KEBONY ASA (NO) | 2011-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150111870-A1 | QUINOLINYL MODULATORS OF RORyt | RORC, RORA, RORB | KDM4E 2003/4885MAPT 2335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.